Xiangmin Cui - Sep 23, 2021 Form 3 Insider Report for Cue Health Inc. (HLTH)

Role
Director, 10%+ Owner
Signature
/s/ Erica Palsis, Attorney-in-Fact for Xiangmin Cui
Stock symbol
HLTH
Transactions as of
Sep 23, 2021
Transactions value $
$0
Form type
3
Date filed
9/23/2021, 09:06 PM
Previous filing
Sep 21, 2021
Next filing
Sep 30, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding HLTH Series C-1 Preferred Stock Sep 23, 2021 Common Stock 8.19M See footnote. F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Series C-1 Preferred Stock automatically converts into the number of shares of Common Stock as shown in Column 3 without payment of further consideration at the holder's election or upon closing of the initial public offering of the Issuer's common stock. The shares have no expiration date.
F2 The securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (''Decheng Fund III''). The general partner of Decheng Fund III is Decheng Capital Management III (Cayman), LLC ("Decheng Capital Management"). The reporting person is the sole manager of Decheng Capital Management and disclaims beneficial ownership of such securities held by Decheng Fund III, except to the extent of his pecuniary interest therein, if any.

Remarks:

Exhibit Index: 24.1 Power of Attorney